Therefore, rather than separating the groups for analysis in WT and AD, instead we grouped animals based on whether a unilateral activation was observed (Iba1+ vs non Iba1-), by an expert blind to the study examining the slides from immunohistochemistry stained for the microglial marker protein Iba-1. The gene discussed is AIF1; the disease is Alzheimer disease.